Civeo (CVEO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 Apr, 2026Executive summary
The annual general meeting will be held virtually on May 27, 2026, with shareholders voting on director elections, executive compensation, an amendment to the equity plan, and auditor ratification.
2025 saw strong growth in Australia, continued right-sizing in Canada, and significant capital returned to shareholders through share repurchases.
Record Australian segment revenues reached $460 million, with a strategic acquisition expanding the village portfolio.
Adjusted EBITDA increased 10% year-over-year to $88 million, and 2.3 million shares were repurchased, representing 17% of shares outstanding at year-end 2024.
Safety performance remained strong, with a global TRIR of 0.27 for 2025, marking the sixth consecutive year under 0.50.
Voting matters and shareholder proposals
Shareholders will vote to elect six directors for one-year terms, approve executive compensation on an advisory basis, amend the 2014 Equity Participation Plan to add 520,920 shares, and ratify Ernst & Young LLP as auditor for 2026.
The board recommends voting FOR all proposals.
Board of directors and corporate governance
The board consists of nine directors, eight of whom are independent; the CEO is the only non-independent member.
Board declassification began in 2024 and will be completed by 2027, after which all directors will serve one-year terms.
Separate Chair and CEO roles, robust director independence, and annual board and committee self-evaluations are in place.
Committees include Audit, Compensation, Environmental/Social/Governance & Nominating, and Finance & Investment, all composed of independent directors.
Director compensation includes cash and equity, with share ownership guidelines requiring directors to hold shares valued at five times the annual retainer.
Latest events from Civeo
- Strong Q4 results, record Australian revenues, and robust buybacks set up a positive 2026 outlook.CVEO
Q4 202528 Apr 2026 - Q2 net income doubled to $8.2M as Australian growth offset Canadian declines; guidance steady.CVEO
Q2 20242 Feb 2026 - Australian growth offsets Canadian declines as Q3 net loss posted, major contract secured.CVEO
Q3 202417 Jan 2026 - Australian growth and contract wins offset Canadian restructuring; 2025 outlook cautious.CVEO
Q4 202424 Dec 2025 - 2025 meeting covers director elections, executive pay, auditor ratification, and ESG progress.CVEO
Proxy Filing1 Dec 2025 - 2025 guidance lowered as share repurchases prioritized amid Canadian and currency headwinds.CVEO
Q1 202528 Nov 2025 - Net loss and revenue drop from Canadian weakness, offset by Australian growth and buybacks.CVEO
Q2 202516 Nov 2025 - Q3 2025 saw strong Australian growth, Canadian cost cuts, and accelerated share buybacks.CVEO
Q3 20252 Nov 2025 - Strong cash flow, growth in Australia, and robust shareholder returns define recent performance.CVEO
Investor Presentation12 Sep 2025